Is Johnson & Johnson Stock a Buy?
Johnson & Johnson is trying a new approach to resolve thousands of outstanding talc lawsuits. The company's operations are growing in the mid-single digits, and investors can expect more of the sam...
Two High Conviction Dividend Buys For This Upside-Down Market
FOMO is driving stock market decisions, especially with meme stocks like GameStop and high-flying AI stocks. That's why I prefer discounted dividend stocks over growth stocks, and highlight two pic...
Johnson & Johnson Completes Acquisition of Proteologix, Inc.
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today that it has successfully completed the acquisition of Proteologix, Inc., a privately-held biotechnology company f...
More than 60 Law Firms Oppose J&J Prepack Bankruptcy Scheme
TRENTON, N.J.--(BUSINESS WIRE)--Some of the nation's largest law firms recognized for their committed and successful representation of individuals harmed by dangerous products have announced unifie...
Beasley Allen and Levin Papantonio: Leading Law Firms Seek Protection for Future Victims of Johnson & Johnson Talc Products
TRENTON, N.J.--(BUSINESS WIRE)--Plaintiffs who are at increased risk of ovarian cancer due to long-term use of Johnson & Johnson's Baby Powder have filed a class action lawsuit in New Jersey federa...
Johnson & Johnson (JNJ) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Talc Plaintiffs File Motion for Temporary Restraining Order to Limit Johnson & Johnson's Use of Bankruptcy Strategy
TRENTON, N.J.--(BUSINESS WIRE)--A group of ovarian cancer victims has filed a motion in federal court seeking to halt Johnson & Johnson (NYSE:JNJ) and its subsidiaries from pursuing a new bankruptc...
Cancer victims ask court to block J&J talc bankruptcy
A group of cancer victims asked a federal judge to block Johnson & Johnson's proposed bankruptcy settlement of tens of thousands of lawsuits alleging the company's baby powder and other talc produc...
7 Recession-Proof Stocks to Buy Now for Peace of Mind
Maintaining stability and security in investment portfolios is vital in an adverse macroeconomic environment. For instance, the current higher-for-longer interest rate environment coupled with othe...
J&J-backed Rapport Therapeutics raises $136 mln in US IPO
Rapport Therapeutics said on Thursday that it has raised $136 million in its initial public offering in the United States at a valuation of about $601.4 million.
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
Johnson & Johnson (JNJ) closed at $145.97 in the latest trading session, marking a -1.24% move from the prior day.
Oregon Jury Awards $260 Million in Mesothelioma Case Against Johnson & Johnson
PORTLAND, Ore.--(BUSINESS WIRE)--A jury in Portland, Ore., has found in favor of a mother of three suffering from the deadly cancer mesothelioma and ordered Johnson & Johnson to pay her $260 millio...
J&J must pay $260 million in latest talc trial, Oregon jury says
Johnson & Johnson must pay $260 million in the case of an Oregon woman who said she got mesothelioma from inhaling the company's talc powder, a jury found on Monday.
3 Magnificent Dividend Stocks to Buy and Hold Forever
Johnson & Johnson is a Dividend King that's investing heavily in R&D and making smart acquisitions. Target is another Dividend King that continually looks for new ways to boost sales.
J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
Data from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study endpoints in depression patients with insomnia symptoms.
Related Companies